Roubini, sometimes known by the moniker Dr Doom, presented in person at the UBS Australasia Conference this week. This wire ...

Swiss money manager cuts mid-2025 and end-2025 targets for MSCI China Index because of tariff uncertainties and disappointing ...

Shares of Altimmune (NASDAQ:ALT) rallied 30% in afternoon trading after the company issued several business updates along ...

Multiple rounds of financial stimulus have slowed the pace of China's economic slowdown, but they've failed to help it ...

UBS Global Wealth Management has cut its forecast for Chinese equities due to rising concerns over potential US tariffs and a ...

The U.S. dollar rose toward a four-month peak versus major peers on Tuesday, while bitcoin extended its record rally as ...

UBS analyst Eliana Merle initiated coverage of Altimmune (ALT) with a Buy rating and $26 price target The firm sees Altimmune as “highly ...

The U.S. Federal Reserve could carry out fewer rate cuts than previously expected next year should President-elect Donald ...

Despite Monday's pullback from record highs, analysts remain bullish on Nvidia's AI chip dominance, raising price targets to ...

We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...

The reason why some are sceptical of J.P. Morgan’s longer-term success in private banking is the US bank’s lack of commitment ...

The USD Index needs to break and hold above 105.70 for a decisive move toward 106.13 and 106.30, UOB Global Economics & Markets Research said. Descending trendline resistance connecting the highs of ...